ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide

NCT06865547 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)

Interventions

BEHAVIORAL: The 4A ProActive Management Model

Sponsor

Yonghong Li